SearchCatalogResearchTools
Research & Educational Use Only. This protocol guide is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before beginning any research protocol.
Oral GLP-1 Receptor Agonist Weekly Protocol Guide

Danuglipron Protocol Guide

✓ Verified dosing (fact-checked against FDA labels / published trials): Route: ORAL tablet (small molecule, not an injectable peptide). No FDA label exists — drug was discontinued April 2025, never approved. Trial dosing (Phase 2b, NCT04707313) was TWICE DAILY: target 40-160 mg BID with stepwise dose escalation — NOT a once-daily morning dose, and NOT a simple "7 tablets/week" regimen (BID = ~14 doses/week). A once-daily… This supersedes any conflicting figures shown elsewhere on this page; confirm with a licensed provider.

Danuglipron is an oral small-molecule GLP-1 receptor agonist developed for weight management and type 2 diabetes research. As an oral formulation, it offers an alternative to injectable GLP-1 therapies. It is being studied in both twice-daily and sustained-release once-daily formulations.

Protocol Overview

Compound
Danuglipron (Small-Molecule GLP-1 Agonist for Weight and T2D Research)
Category
Oral GLP-1 Receptor Agonist
Vial Size
Oral tablet (Per label)
Reconstitution
N/A (oral tablet)
Route
Oral
Frequency
7 days/week

Administration

Take orally with water. No reconstitution or injection required.

  • Take with or without food (unless otherwise noted)
  • Store at room temperature in a cool, dry place
  • Follow the dosing schedule consistently

Administration Guidelines

  • Take orally once or twice daily as directed by protocol
  • Dose per product label - follow specific titration schedule provided
  • Swallow tablet whole with water
  • May be taken with or without food depending on formulation
  • If a dose is missed skip it and resume at next scheduled time
  • Store tablets at room temperature in original packaging
  • Protect from moisture and light
  • Document administration times and observations

Storage Requirements

StateStorage Conditions
Sealed containerRoom temperature, cool dry place, protect from moisture
Opened containerRoom temperature, keep sealed, use within 90 days
Share & Save
X Share on Twitter R Share on Reddit W WhatsApp E Email L Copy Link P Print / Save PDF * Save to Favorites
⚠ Before any use: human safety data is limited or absent for many of these compounds. Consult a licensed healthcare provider first — especially if you are pregnant or nursing, have a medical condition, or take other medications.